Home › Leukemia › Alabama › Birmingham

Pag-aaral pangklinika para sa Leukemia sa Birmingham, AL

Isang pag-aaral para sa Leukemia ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Birmingham. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia

Nagre-recruitPhase 3

University of Alabama at Birmingham (UAB), Birmingham

Edad 18 hanggang 71 · Lahat ng kasarian · Na-update Okt 30, 2026 · NCT07504458

Trial of 2 Step ATG for Prevention of Acute GVHD Post Allogeneic Stem Cell Transplant

Nagre-recruitPhase 2

University of Alabama at Birmingham, Birmingham

Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Okt 29, 2026 · NCT06265584

Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies

Nagre-recruitObservasyonal na pag-aaral

Children's Hospital of Alabama, Birmingham

Lahat ng edad · Lahat ng kasarian · Na-update Okt 20, 2026 · NCT00736749

Trial of 2 Step ATG for Acute GVHD Prevention Post Myeloablative Allogeneic Stem Cell Transplant

Nagre-recruitPhase 2

University of Alabama at Birmingham, Birmingham

Edad 18 hanggang 60 · Lahat ng kasarian · Na-update Okt 9, 2026 · NCT06315309

Evaluation of Two Dose Levels of Quizartinib as Maintenance in FLT3-ITD (+) Acute Myeloid Leukemia Patients in Complete Remission

Nagre-recruitPhase 2

University of Alabama - Birmingham, Birmingham

Edad 18 pataas · Lahat ng kasarian · Na-update Set 16, 2026 · NCT06824168

Dose-Expansion Study of Low Dose Post-Transplant Cyclophosphamide/Tacrolimus/Ruxolitinib for Graft-versus-Host Disease (GVHD) Prophylaxis in Myeloablative Allogeneic Peripheral Blood Stem Cell Transplantation

Nagre-recruitPhase 2

The University of Alabama at Birmingham, Birmingham

Edad 18 pataas · Lahat ng kasarian · Na-update Set 2, 2026 · NCT07249346

A Study of DR-01 in Subjects With Large Granular Lymphocytic Leukemia or Cytotoxic Lymphomas

Nagre-recruitPhase 1/2

Dren Investigational Site, Birmingham

Edad 18 pataas · Lahat ng kasarian · Na-update Hun 17, 2026 · NCT05475925

Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment

Nagre-recruitObservasyonal na pag-aaral

Children's Hospital of Alabama, Birmingham

Lahat ng edad · Lahat ng kasarian · Na-update May 18, 2026 · NCT01790152

Trial of Novel Anti-leukemia Agents in Flu/Mel RIC Transplant for Myeloid Malignancies

Nagre-recruitPhase 1

University of Alabama at Birmingham, Birmingham

Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Mar 4, 2026 · NCT07044544

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Nagre-recruitObservasyonal na pag-aaral

Massive Bio SYNERGY-AI site, Birmingham

Lahat ng edad · Lahat ng kasarian · Na-update Okt 28, 2025 · NCT03452774

Study of VIP943 in Subjects With Advanced CD123+ Hematologic Malignancies

Nagre-recruitPhase 1

University of Alabama at Birmingham, Birmingham

Edad 18 pataas · Lahat ng kasarian · Na-update Nob 15, 2024 · NCT06034275

Pag-aaral para sa Leukemia sa ibang lungsod

Iba pang pag-aaral sa Birmingham

Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.